Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

Presentation TCT 2025

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2024

Reimbursement Controversies: Does the System Work for Anyone?

Presenter: Josh Makower

October 28, 2024

Presentation TCT 2024

CMS Hot Topics: A Primer on the New TCET Regulations

Presenter: Steven Farmer

October 28, 2024

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

Todd Neale

October 27, 2024

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2022

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

Presenter: Aaron Kaplan

September 18, 2022

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

Presentation TCT 2018

CMS Strategy and the Move to Value

Presenter: Peter L Duffy, Timothy D. Henry, John A. Spertus

September 24, 2018

Presentation TCT 2018

CMS Perspectives

Presenter: Lori M Ashby

September 22, 2018

Presentation TCT 2018

CMS Requirement for Reimbursement for Innovation

Presenter: Spencer B. King III, Bram D. Zuckerman, Lori M Ashby

September 21, 2018

Presentation TCT 2017

CMS Strategy and the Move to Value

Presenter: Peter L Duffy, Hadley Wilson, John A. Spertus

October 31, 2017

Presentation TCT 2017

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos

October 30, 2017

Presentation TCT 2015

The Evolving CMS Reimbursement Process: How Can CMS Promote Innovation, and What Clinical Data Make a Difference?

Presenter: Aaron V. Kaplan, James Rollins

October 13, 2015

News Conference News TCT 2014

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

September 16, 2014

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Regulation of Cardiovascular Devices in Europe: A Need for Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Angeles Alonso Garcia

September 15, 2014

Presentation TCT 2014

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Jack C. Lewin

September 15, 2014

Advertisement

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Reimbursement Controversies: Does the System Work for Anyone?

CMS Hot Topics: A Primer on the New TCET Regulations

LAAO Outcomes Similar Regardless of Operator’s Specialty

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Regulatory Innovation Revisited: Blending Patient Needs, Industry Imperatives, Health Policy, and Reimbursement

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Surgical Volume Matters When It Comes to Repair of Primary MR

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

CMS Strategy and the Move to Value

CMS Perspectives

CMS Requirement for Reimbursement for Innovation

CMS Strategy and the Move to Value

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

The Evolving CMS Reimbursement Process: How Can CMS Promote Innovation, and What Clinical Data Make a Difference?

Affordable Care Act-Related Changes Hold Promise for Future of Device Innovation, Physician Payments

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Regulation of Cardiovascular Devices in Europe: A Need for Change

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content